跳至主要内容
临床试验/NCT07249697
NCT07249697已完成不适用

Risk Factors for Poor Prognosis in Neonatal Necrotizing Enterocolitis

Guangzhou Women and Children's Medical Center1 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2017年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
118
试验地点
1
主要终点
In-hospital mortality

研究概览

简要总结

This is a retrospective study led by Guangzhou Women and Children's Medical Center, focusing on newborns diagnosed with necrotizing enterocolitis (NEC)-a serious gastrointestinal disease that threatens newborns' lives-between January 2017 and December 2022.

Purpose of the study: NEC can lead to severe conditions like bowel perforation or even death, and it's hard for doctors to spot high-risk babies early with current tools. This study aims to analyze the babies' clinical information (e.g., birth weight, symptoms like belly swelling or bloody stools), blood test results (e.g., lactate levels, white blood cell counts), and organ function scores (nSOFA scores) to find indicators that can predict whether NEC will get worse or cause death.

Questions the study tries to answer: Can combining metabolic indicators (like lactate), blood test parameters, and organ function scores better predict if a newborn with NEC will develop perforated NEC (a more severe form where the bowel has holes) or die during hospitalization? Are these combined indicators more reliable than single indicators alone? Study hypothesis: We guess that integrating metabolic markers (such as lactate), blood routine parameters, and nSOFA scores will be more accurate than using any single indicator to predict the progression of NEC and the risk of death in affected newborns.

详细描述

  1. Study Rationale Necrotizing Enterocolitis (NEC) is a life-threatening gastrointestinal disorder primarily affecting very low birth weight (VLBW) neonates (incidence: 5-12%). Around 20-40% of cases progress to severe disease requiring surgery, and survivors often face long-term complications (e.g., short-bowel syndrome, neurodevelopmental impairments). Despite advances in neonatal care, early identification of high-risk patients remains challenging due to nonspecific clinical/radiographic signs and insufficiently sensitive/specific conventional biomarkers.

NEC pathophysiology involves intestinal ischemia-reperfusion injury, excessive immune activation, and microbial dysbiosis. Serum lactate (a marker of hypoperfusion/anaerobic metabolism) correlates with NEC severity but lacks specificity; peripheral blood cell (CBC) indices are accessible but understudied in combination with lactate. The Neonatal Sequential Organ Failure Assessment (nSOFA) score predicts overall NEC mortality but fails to stratify risk for perforated NEC (PNEC), a high-risk subtype. This study aims to address gaps by integrating metabolic (lactate), hematologic (CBC), and organ dysfunction (nSOFA) metrics for NEC prognosis. 2. Study Design and Conduct This is a retrospective cohort study conducted at the Guangzhou Women and Children's Medical Center, approved by the institutional ethics committee and compliant with the Helsinki Declaration. The study period is January 2017 and December 2022; eligible participants are identified via retrospective review of electronic medical records (EMRs), with data extracted in a structured manner. 3. Data Collection

Structured EMR extraction captures key variables:

Neonatal history: Sex, gestational age, birth weight, birth asphyxia (Apgar scores), small for gestational age (SGA) status, preterm complications (e.g., patent ductus arteriosus [PDA], respiratory distress syndrome [RDS]), feeding pattern, mechanical ventilation use.

Maternal history: Delivery mode, chorioamnionitis, premature rupture of membranes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
1 Day 至 3 Months(Child)
性别
All
接受健康志愿者

入选标准

  • (1) Diagnosis of NEC;

排除标准

  • Congenital gastrointestinal malformations (e.g., intestinal atresia, Hirschsprung's disease) or spontaneous intestinal perforation;
  • Hereditary metabolic disorders;
  • refusal of participation.

结局指标

主要结局

In-hospital mortality

时间窗: Day 1 up to 3 months

In-hospital mortality

Occurrence of perforated necrotizing enterocolitis

时间窗: Day 1 up to 3 months

Occurrence of perforated necrotizing enterocolitis

次要结局

  • Bell's Staging System for Necrotizing Enterocolitis (NEC)(Day 1 up to 3 months)
  • Incidence of Surgical Necrotizing Enterocolitis (NEC)(Day 1 up to 3 months)

研究者

发起方
Guangzhou Women and Children's Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wei Zhou

Principal Investigator

Guangzhou Women and Children's Medical Center

研究点 (1)

Loading locations...

相似试验